Reply to Commentary by Cummings (2022): Surrogate endpoints extend beyond biomarkers

被引：1
|
作者：
Manyara, Anthony Muchai [1 ]
Ciani, Oriana [2 ]
Taylor, Rod S. [1 ,3 ]
机构：
[1] Univ Glasgow, MRC CSO Social & Publ Hlth Sci Unit, Berkeley Sq,99 Berkeley St, Glasgow G3 7HR, Lanark, Scotland
[2] SDA Bocconi Sch Management, Milan, Italy
[3] Univ Glasgow, Roberston Ctr Biostat, Inst Hlth & Wellbeing, Glasgow, Lanark, Scotland
来源：
ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS | 2022年 / 8卷 / 01期
基金：
英国医学研究理事会;
关键词：
D O I：
10.1002/trc2.12344
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Biomarkers in Alzheimer's Disease Not Yet Surrogate Endpoints
    Coley, N.
    Andrieu, S.
    Delrieu, J.
    Voisin, T.
    Vellas, B.
    BIOMARKERS IN BRAIN DISEASE, 2009, 1180 : 119 - 124
  • [22] Foreword: Biomarkers and Surrogate Endpoints in Ophthalmic Clinical Research
    Villani, Edoardo
    Vujosevic, Stela
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (06) : BIOI - BIOII
  • [23] Biomarkers and Surrogate Endpoints Developing Common Terminology and Definitions
    Robb, Melissa A.
    McInnes, Pamela M.
    Califf, Robert M.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 315 (11): : 1107 - 1108
  • [24] Optimizing the use of biomarkers, surrogate endpoints, and clinical endpoints for more efficient drug development
    Colburn, WA
    JOURNAL OF CLINICAL PHARMACOLOGY, 2000, 40 (12): : 1419 - 1427
  • [25] Surrogate endpoints for new colorectal cancer drugs - Reply
    Croockewit, A
    Schellens, J
    van Bronswijk, H
    Lekkerkerker, JF
    Koopmans, PP
    LANCET, 2000, 356 (9243): : 1771 - 1771
  • [26] Biomarkers and Surrogate Endpoints in Drug Development: A European Regulatory View
    Wickstrom, Kerstin
    Moseley, Jane
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (06) : BIO27 - BIO33
  • [27] Biomarkers and surrogate endpoints in clinical research - some statistical challenges
    Buyse, M.
    EJC SUPPLEMENTS, 2008, 6 (09): : 120 - 120
  • [28] Biomarkers as surrogate endpoints in Alzheimer's disease clinical trials
    Kritsidima, M.
    Elferink, A. J.
    Wied, C. C. Gispen-de
    EUROPEAN JOURNAL OF NEUROLOGY, 2008, 15 : 33 - 33
  • [29] Biomarkers and surrogate endpoints in clinical research: definitions and conceptual model
    BIOMARKERS AND SURROGATE ENDPOINTS: CLINICAL RESEARCH AND APPLICATIONS, 2000, 1205 : 1 - 9
  • [30] Commentary on: A call for better reporting of trials using surrogate primary endpoints
    Cummings, Jeffrey
    ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS, 2022, 8 (01)
12345